Vaccines,
Год журнала:
2021,
Номер
9(7), С. 781 - 781
Опубликована: Июль 13, 2021
The
clinical
trials
of
the
COVID-19
vaccines
that
are
authorized
in
European
Union
have
revealed
high
efficacy
preventing
symptomatic
infections.
However,
during
vaccination
campaigns,
some
vaccine
recipients,
including
those
partially
and
fully
vaccinated,
will
experience
severe
COVID-19,
requiring
hospitalization.
This
may
particularly
concern
patients
with
a
diminished
immune
response
to
vaccine,
as
well
non-responders.
work
has
retrospectively
analyzed
92
cases
who
were
hospitalized
between
27
December
2020
31
May
2021
four
Polish
healthcare
units
due
previously
received
(54.3%
≤
14
days
after
first
dose,
26.1%
>
7.6%
second
12%
dose).
These
represented
minute
fraction
(1.2%)
all
same
period
institutions.
No
significant
differences
white
blood
count,
absolute
lymphocyte
count
nadir,
C-reactive
protein,
interleukin-6,
procalcitonin,
oxygen
saturation,
lung
involvement,
fever
frequency
found
recipients
dose.
A
total
15
deaths
noted
(1.1%
fatal
considered
units),
six
dose
(five
dose)-three
these
subjects
using
immunosuppressive
medicines,
two
confirmed
be
study
reassures
not
common
vaccinated
individuals,
highlights
course
such
reveal
any
distinctive
features,
advocates
for
close
monitoring
at
higher
risk
failure.
Journal of Medical Virology,
Год журнала:
2021,
Номер
93(7), С. 4280 - 4291
Опубликована: Март 1, 2021
Abstract
Background
Vaccine
hesitancy
poses
serious
challenges
for
achieving
coverage
population
immunity.
It
is
necessary
to
achieve
high
COVID‐19
vaccination
acceptance
rates
and
medical
students’
as
future
health
care
providers.
The
study
aimed
explore
the
level
of
vaccine
determine
factors
barriers
that
may
affect
decision‐making.
Methods
A
cross‐sectional
was
carried
out
among
students
in
Tanta
Kafrelsheikh
Universities,
Egypt.
Data
collection
done
via
an
online
questionnaire
during
January
2021
from
2133
students.
Results
majority
participant
(90.5%)
perceived
importance
vaccine,
46%
had
hesitancy,
equal
percentage
(6%)
either
definitely
accepted
or
refused
vaccine.
Most
concerns
regarding
vaccine's
adverse
effects
(96.8%)
ineffectiveness
(93.2%).
most
confirmed
were
deficient
data
(potential
74.17%
unknown
56.31%)
insufficient
information
itself
(72.76%).
Conclusion
government,
authority
decision‐makers,
experts,
universities
Egypt
need
work
together
make
efforts
reduce
raise
awareness
about
vaccinations,
consequently
improving
vaccines.
PLoS ONE,
Год журнала:
2022,
Номер
17(3), С. e0265496 - e0265496
Опубликована: Март 23, 2022
Although
vaccines
are
considered
the
most
effective
and
fundamental
therapeutic
tools
for
consistently
preventing
COVID-19
disease,
worldwide
vaccine
hesitancy
has
become
a
widespread
public
health
issue
successful
immunization.
The
aim
of
this
review
was
to
identify
an
up-to-date
concise
assessment
potential
factors
influencing
acceptance
refusal
intention,
outline
key
message
in
order
organize
these
according
country
count.
Vaccines,
Год журнала:
2021,
Номер
9(3), С. 250 - 250
Опубликована: Март 12, 2021
South
Africa
became
one
of
the
first
African
countries
to
receive
COVID-19
vaccine.
As
rest
prepares
vaccines,
most
in
have
set
up
national-level
coordination
committees
for
developing
national
vaccination
deployment
plans.
While
main
focus
these
has
been
on
setting
strategies
that
facilitate
swift
distribution
vaccines
once
they
are
available,
role
effective
public
health
awareness
should
not
be
ignored.
Countries
must
devise
how
best
enhance
understanding
and
curb
misinformation
about
vaccines.
With
this
viewpoint,
we
unpack
threat
vaccine
hesitancy
offer
recommendations
communication
Zimbabwean
contexts.
Vaccines,
Год журнала:
2021,
Номер
9(4), С. 382 - 382
Опубликована: Апрель 14, 2021
Vaccine
hesitancy
is
a
major
threat
to
the
success
of
COVID-19
vaccination
programs.
The
present
cross-sectional
online
survey
adult
Poles
(n
=
1020)
expressing
willingness
receive
vaccine
was
conducted
between
February
and
March
2021
aimed
assess
(i)
general
trust
in
different
types
vaccines,
(ii)
level
acceptance
vaccines
already
use
Poland
(BNT162b2
by
BioNTech/Pfizer,
mRNA-1273
Moderna
AZD1222
Oxford/AstraZeneca)
as
well
eight
approved
outside
European
Union
(EU)
or
advanced
stages
clinical
trials,
(iii)
fear
against
COVID-19,
(iv)
main
sources
information
on
vaccination.
Among
all
technology,
highest
observed
for
mRNA
platform,
with
considerable
number
surveyed
(>20%)
not
aware
existence
produced
using
traditional
approach
(inactivated
live
attenuated
vaccines).
age
participants
factor
differentiating
particular
type.
Both
BNT162b
received
high
acceptance,
contrary
AZD1222.
From
unauthorized
EU
at
moment
study,
CVnCoV
(mRNA;
CureVac)
met
trust,
followed
Ad26.COV2.S
(vector;
Janssen/Johnson&Johnson)
NVX-CoV2373
(protein;
Novavax).
Sputnik
V
Gamaleya
Research
Institute)
decidedly
least
trusted
vaccine.
median
(measured
10-point
Likert-type
scale)
studied
group
4.0,
mostly
related
risk
serious
allergic
reactions,
other
severe
adverse
events
unknown
long-term
effects
Female,
individuals
lower
education
those
seeking
any
revealed
higher
Experts’
materials
were
source
group.
study
shows
can
vary
much
across
producers
while
are
acceptance.
It
also
emphasizes
need
effective
continuous
science
communication
when
fighting
pandemic
it
may
be
an
ideal
time
increase
awareness
vaccines.
Vaccines,
Год журнала:
2021,
Номер
9(4), С. 379 - 379
Опубликована: Апрель 13, 2021
The
success
of
mass
COVID-19
vaccination
campaigns
rests
on
widespread
uptake.
However,
although
vaccinations
provide
good
protection,
they
do
not
offer
full
immunity
and
while
likely
reduce
transmission
the
virus
to
others,
extent
this
remains
uncertain.
This
produces
a
dilemma
for
communicators
who
wish
be
transparent
about
benefits
harms
encourage
continued
caution
in
vaccinated
individuals
but
undermine
confidence
an
important
public
health
measure.
In
two
large
pre-registered
experimental
studies
quota-sampled
UK
participants
we
investigate
effects
providing
communication—including
uncertainty—about
effectiveness
decision-making.
Study
1
(n
=
2097)
report
that
detailed
information
vaccines,
including
results
clinical
trials,
does
have
significant
impact
beliefs
efficacy
such
concerns
over
side
effects,
or
intentions
receive
vaccine.
2
2217)
addressed
highlighting
need
maintain
protective
behaviours
(e.g.,
social
distancing)
post-vaccination
may
lower
perceptions
vaccine
willingness
We
find
evidence
this:
messages
did
significantly
efficacy,
some
cases
increased
efficacy.
again
no
main
effect
both
suggest
transparently
informing
people
limitations
neither
it
increase
engage
post-vaccination.
Vaccines,
Год журнала:
2021,
Номер
9(5), С. 433 - 433
Опубликована: Апрель 27, 2021
Since
the
worldwide
COVID-19
pandemic
was
declared
a
year
ago,
search
for
vaccines
has
become
top
priority
in
order
to
restore
normalcy
after
2.5
million
deaths
worldwide,
overloaded
sanitary
systems,
and
huge
economic
burden.
Vaccine
development
represented
step
towards
desired
herd
immunity
short
period
of
time,
owing
high
level
investment,
focus
researchers,
urge
authorization
faster
administration
vaccines.
Nevertheless,
this
objective
may
only
be
achieved
by
pursuing
effective
strategies
policies
various
countries
worldwide.
In
present
review,
some
aspects
involved
accomplishing
successful
vaccination
program
are
addressed,
addition
importance
face
unwillingness,
conspiracy
theories,
or
lack
information
among
public.
Moreover,
we
provide
updated
points
related
landscape
clinical
vaccine
candidates,
specifically,
five
that
already
being
assessed
Phase
IV
trials
(BNT162b2,
mRNA-1273,
AZD1222,
Ad26.COV2.S,
CoronaVac).
Abstract
Background
Vaccination
against
COVID-19
has
been
available
in
Germany
since
December
2020.
However,
about
30%
of
the
population
report
not
wanting
to
be
vaccinated.
In
order
increase
willingness
get
vaccinated,
data
on
acceptance
vaccination
and
its
influencing
factors
are
necessary.
Little
is
known
why
individuals
refuse
vaccination.
The
aim
this
study
was
investigate
reasons
leading
rejecting
vaccination,
based
posts
from
three
social
media
sites.
Methods
German-language
versions
Instagram,
Twitter
YouTube
were
searched
regarding
negative
attitudes
towards
Data
extracted
until
a
saturation
effect
could
observed.
included
created
January
20,
2020
May
2,
2021.
This
time
frame
roughly
covers
period
first
reports
spread
SARS-CoV-2
up
general
availability
vaccines
Germany.
We
used
an
interpretive
thematic
approach
analyze
inductively
generate
codes,
subcategories
categories.
Results
Based
333
written
by
323
contributing
users,
we
identified
six
main
categories
for
refusing
vaccination:
Low
perceived
benefit
low
risk
contracting
COVID-19,
health
concerns,
lack
information,
systemic
mistrust
spiritual
or
religious
reasons.
analysis
reveals
information
among
users
misinformation
with
regard
Users
feel
inadequately
informed
do
understand
available.
These
gaps
may
related
being
sufficiently
sensitive
needs
target
group.
addition
limited
population,
internet
can
also
important
reason
Conclusions
emphasizes
relevance
providing
trustworthy
quality-assured
all
groups.
addition,
vaccinations
should
easily
accessible
promote
population’s
Pharmacological Reports,
Год журнала:
2022,
Номер
74(6), С. 1255 - 1278
Опубликована: Июль 25, 2022
The
use
of
antiviral
COVID-19
medications
can
successfully
inhibit
SARS-CoV-2
replication
and
prevent
disease
progression
to
a
more
severe
form.
However,
the
timing
treatment
plays
crucial
role
in
this
regard.
Oral
drugs
provide
an
opportunity
manage
infection
without
need
for
hospital
admission,
easing
general
burden
that
have
on
healthcare
system.
This
review
paper
(i)
presents
potential
pharmaceutical
targets,
including
various
host-based
targets
viral-based
(ii)
characterizes
first-generation
anti-SARS-CoV-2
oral
(nirmatrelvir/ritonavir
molnupiravir),
(iii)
summarizes
clinical
progress
other
antivirals
COVID-19,
(iv)
discusses
ethical
issues
such
trials
(v)
challenges
associated
with
practice.
represent
part
strategy
adapt
long-term
co-existence
manner
prevents
from
being
overwhelmed.
It
is
pivotal
ensure
equal
fair
global
access
currently
available
those
authorized
future.
Abstract
Background
Human
Papilloma
Virus
(HPV)
is
the
most
common
sexually
transmitted
infection
worldwide.
Globally,
both
men
and
women
have
a
50%
risk
of
being
infected
at
least
once
in
their
life.
HPV
prevalence
among
highest
sub-Saharan
Africa
(SSA),
an
average
24%.
causes
different
types
cancers,
including
cervical
cancer
(CC),
which
leading
cause
deaths
SSA.
HPV-vaccination
has
been
proven
to
be
effective
reducing
induced
cancers.
SSA
countries
are
delayed
reaching
WHO’s
target
fully
vaccinating
90%
girls
within
age
15
by
2030.
Our
systematic
review
aims
identify
barriers
facilitators
inform
national
implementation
strategies
region.
Methods
This
mixed
method
based
on
PRISMA
statement
The
Joanna
Briggs
Institute
Reviewers’
Manual.
Search
were
adapted
each
selected
database:
PubMed/MEDLINE,
Livivo,
Google
Scholar,
Science
Direct,
African
Journals
Online
for
papers
published
English,
Italian,
German,
French
Spanish
between
1
December
2011
31
2021.
Zotero
Rayyan
software
used
data
management.
appraisal
was
conducted
three
independent
reviewers.
Results
A
total
20
articles
from
initial
536
articles.
Barriers
included:
limited
health
system
capacities,
socio-economic
status,
stigma,
fear
costs
vaccines,
negative
experience
with
vaccinations,
COVID-19
pandemic,
lack
correct
information,
education
(HE)
consent.
Additionally,
we
found
that
boys
scarcely
considered
parents
stakeholders.
Facilitators
information
knowledge,
policy
implementation,
positive
HE,
stakeholders’
engagement,
women’s
empowerment,
community
seasonality,
target-oriented
vaccination
campaigns.
Conclusions
synthesizes
HPV-vaccinations
Addressing
these
can
contribute
more
immunization
programs
targeted
eliminating
CC
line
WHO
90/70/90
strategy.
Registration
funding
Protocol
ID:
CRD42022338609
registered
International
Prospective
Register
Systematic
Reviews
(PROSPERO).
Partial
funds:
German
Centre
Infection
research
(DZIF)
project
NAMASTE:
8,008,803,819.
Mathematics,
Год журнала:
2023,
Номер
11(3), С. 508 - 508
Опубликована: Янв. 18, 2023
With
the
current
shift
in
mass
media
landscape
from
journalistic
rigor
to
social
media,
personalized
is
becoming
new
norm.
Although
digitalization
progress
of
brings
many
advantages,
it
also
increases
risk
spreading
disinformation,
misinformation,
and
malformation
through
use
fake
news.
The
emergence
this
harmful
phenomenon
has
managed
polarize
society
manipulate
public
opinion
on
particular
topics,
e.g.,
elections,
vaccinations,
etc.
Such
information
propagated
can
distort
perceptions
generate
unrest
while
lacking
traditional
journalism.
Natural
Language
Processing
Machine
Learning
techniques
are
essential
for
developing
efficient
tools
that
detect
Models
context
textual
data
resolving
news
detection
problem,
as
they
manage
encode
linguistic
features
within
vector
representation
words.
In
paper,
we
propose
a
approach
uses
document
embeddings
build
multiple
models
accurately
label
articles
reliable
or
fake.
We
present
benchmark
different
architectures
using
binary
multi-labeled
classification.
evaluated
five
large
corpora
accuracy,
precision,
recall.
obtained
better
results
than
more
complex
state-of-the-art
Deep
Neural
Network
models.
observe
most
important
factor
obtaining
high
accuracy
encoding,
not
classification
model's
complexity.